Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study

Table 3 Postoperative liver function and complications

Variable	RF(-) group	RF(+) group	P value
	(n = 79)	(n = 100)
ALT (U/L)1
POD 1	245.5 (54-1412)	348.5 (88-1640)	0.01
POD 3	220 (47-1632)	260 (79-1532)	0.24
POD 5	82.5 (18-1330)	112 (27-2403)	0.00
AST (U/L)1
POD 1	268 (65-1483)	446 (117-1795)	0.00
POD 3	125 (28-1787)	129.5 (36-710)	0.65
POD 5	50 (20-930)	52.5 (19-3681)	0.10
TBIL (mg/dL)1
POD 1	1.39 (0.58-3.76)	1.61 (0.52-3.71)	0.30
POD 3	1.57 (0.52-5.73)	1.39 (0.39-6.95)	0.08
POD 5	1.19 (0.51-4.62)	1.17 (0.47-5.05)	0.93
PT(s)1
POD 1	14.3 (12-20)	14.1 (11-21)	0.73
POD 3	14.1 (12-22)	14.0 (10-36)	0.57
POD 5	13.8 (12-20)	13.7 (11-22)	0.89
Complications, n (%)
Overall mobility	14 (17.7)	28 (28.0)	0.11
Abscess	3 (3.8)	3 (3.0)	1.00
Biliary fistula	2 (2.5)	7 (7.0)	0.31
Ascites	1 (1.2)	2 (2.0)	1.00
Pleural effusion	4 (5.1)	6 (6.0)	1.00
Pneumonia	4 (5.1)	4 (4.0)	1.00
Liver failure	0	6 (6.0)	0.04
30-d mortality	0	3 (3.0)	0.26
Hospital stay (d)1	21(12-70)	22 (13-71)	0.96

¹Non-normal distribution data analyzed with the Mann-Whitney test.